PARSONS CAPITAL MANAGEMENT INC/RI - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
PARSONS CAPITAL MANAGEMENT INC/RI ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,922,246
+36.0%
974,082
+11.5%
0.23%
+40.9%
Q2 2023$2,148,348
+31.6%
873,312
+20.9%
0.16%
+25.2%
Q1 2023$1,632,096
-5.8%
722,166
+45.5%
0.13%
-9.7%
Q4 2022$1,731,926
-90.7%
496,254
-1.5%
0.14%
-91.3%
Q3 2022$18,651,000
+95.0%
503,801
+0.0%
1.67%
+94.7%
Q2 2022$9,567,000
-29.5%
503,776
+0.1%
0.86%
-16.2%
Q1 2022$13,578,000
+19.7%
503,076
-0.1%
1.03%
+26.2%
Q4 2021$11,342,000
-8.5%
503,412
+6.4%
0.81%
-16.1%
Q3 2021$12,397,000
-14.0%
472,974
+5.0%
0.97%
-12.1%
Q2 2021$14,418,000
-9.3%
450,412
-0.2%
1.10%
-15.2%
Q1 2021$15,894,000
+9.7%
451,412
-0.0%
1.30%
+4.2%
Q4 2020$14,483,000
-15.4%
451,612
-0.8%
1.25%
-25.3%
Q3 2020$17,122,000
-15.7%
455,137
+0.2%
1.67%
-22.8%
Q2 2020$20,320,000
+40.0%
454,087
+6.7%
2.16%
+15.7%
Q1 2020$14,516,000
+1.4%
425,575
+16.0%
1.87%
+30.2%
Q4 2019$14,310,000366,9331.44%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders